KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Diluted Average) (2016 - 2025)

Edwards Lifesciences (EW) has 15 years of Shares Outstanding (Diluted Average) data on record, last reported at $585.8 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 2.25% year-over-year to $585.8 million; the TTM value through Dec 2025 reached $585.8 million, down 2.25%, while the annual FY2025 figure was $585.8 million, 2.25% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $585.8 million in Q4 2025 per EW's latest filing, roughly flat from $587.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $631.3 million in Q1 2021 and bottomed at $585.8 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $611.5 million, with a median of $609.9 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 0.35% in 2021, then fell 2.94% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $631.2 million in 2021, then dropped by 1.11% to $624.2 million in 2022, then fell by 2.37% to $609.4 million in 2023, then decreased by 1.66% to $599.3 million in 2024, then dropped by 2.25% to $585.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $585.8 million in Q4 2025, $587.2 million in Q3 2025, and $587.9 million in Q2 2025.